2003
DOI: 10.1074/jbc.m211558200
|View full text |Cite
|
Sign up to set email alerts
|

Identification of the NF-E2-related Factor-2-dependent Genes Conferring Protection against Oxidative Stress in Primary Cortical Astrocytes Using Oligonucleotide Microarray Analysis

Abstract: The antioxidant responsive element (ARE) mediates transcriptional regulation of phase II detoxification enzymes and antioxidant proteins such as NAD(P)H:quinone oxidoreductase (NQO1), glutathione S-transferases, and glutamate-cysteine ligase. In this study, we demonstrate that NF-E2-related factor-2 (Nrf2) plays a major role in transcriptional activation of ARE-driven genes and identify Nrf2-dependent genes by oligonucleotide microarray analysis using primary cortical astrocytes from Nrf2 ؉/؉ and Nrf2 ؊/؊ mice… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

22
512
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 695 publications
(534 citation statements)
references
References 58 publications
22
512
0
Order By: Relevance
“…Hence, the Nrf2‐ARE pathway is considered a high‐value therapeutic target (de Vries et al, 2008; Johnson and Johnson, 2015; van Muiswinkel and Kuiperij, 2005). It is preferentially activated in astrocytes while neurons largely depend on astrocytes for the antioxidant defense (Kraft, Johnson, & Johnson, 2004; Lee, Calkins, Chan, Kan, & Johnson, 2003; Shih et al, 2003). Therefore, unsurprisingly, many studies report that activation of the Nrf2 pathway in astrocytes is neuroprotective (Calkins, Vargas, Johnson, & Johnson, 2010; Chen et al, 2009; Gan, Vargas, Johnson, & Johnson, 2012; Vargas, Johnson, Sirkis, Messing, & Johnson, 2008).…”
Section: Potential Therapeutic Targets In Astrocytesmentioning
confidence: 99%
“…Hence, the Nrf2‐ARE pathway is considered a high‐value therapeutic target (de Vries et al, 2008; Johnson and Johnson, 2015; van Muiswinkel and Kuiperij, 2005). It is preferentially activated in astrocytes while neurons largely depend on astrocytes for the antioxidant defense (Kraft, Johnson, & Johnson, 2004; Lee, Calkins, Chan, Kan, & Johnson, 2003; Shih et al, 2003). Therefore, unsurprisingly, many studies report that activation of the Nrf2 pathway in astrocytes is neuroprotective (Calkins, Vargas, Johnson, & Johnson, 2010; Chen et al, 2009; Gan, Vargas, Johnson, & Johnson, 2012; Vargas, Johnson, Sirkis, Messing, & Johnson, 2008).…”
Section: Potential Therapeutic Targets In Astrocytesmentioning
confidence: 99%
“…The primary astrocyte of Nrf2 À/À mice is also more susceptible to oxidative stress and inflammation than that of Nrf2 þ / þ mice. 6 Leung et al 7 showed that deficiency of Nrf2 results in early embryonic lethality with severe oxidative stress. These observations, collectively, imply that Nrf2 is a master regulator of ARE-driven transcriptional activation for antioxidant genes in maintaining the homeostasis of Redox status within cells.…”
Section: Introductionmentioning
confidence: 99%
“…The transcription factor Nrf2 is a central protein that regulates the transcription of multiple antioxidant enzyme genes in mice primary cortical astrocytes (Lee et al, 2003). In mice, the up-regulation of Nrf2 expression in the lung induced greater expression of Nrf2 target antioxidant genes, such as CAT and GPx (Blake et al, 2010).…”
Section: Protective Effect Of Leucine On Oxidative Damage In Musclementioning
confidence: 99%